SMART isn't

Journal of Allergy and Clinical Immunology

Volumn 125, Issue 3, 2010, Pages 609-610

  Chapman, Kenneth R ^a  

^a TORONTO WESTERN HOSPITAL   (Canada)

Author keywords

Asthma; budesonide; control; exacerbations; formoterol; guidelines

Indexed keywords

BETA ADRENERGIC RECEPTOR STIMULATING AGENT; BUDESONIDE; BUDESONIDE PLUS FORMOTEROL; CORTICOSTEROID;

AIRWAY INFLAMMATION; ASTHMA; DISEASE CLASSIFICATION; DISEASE CONTROL; DISEASE EXACERBATION; EDITORIAL; EMERGENCY CARE; EOSINOPHIL COUNT; HOSPITAL CARE; HUMAN; LOW DRUG DOSE; LUNG FUNCTION; MONOTHERAPY; MORTALITY; PRACTICE GUIDELINE; PRIORITY JOURNAL; QUALITY OF LIFE; RESPIRATORY TRACT DISEASE; THERAPY EFFECT; TREATMENT OUTCOME; TREATMENT RESPONSE;

ANTI-ASTHMATIC AGENTS; ASTHMA; BUDESONIDE; CLINICAL TRIALS AS TOPIC; DRUG COMBINATIONS; ETHANOLAMINES; HUMANS;

EID: 77749315600     PISSN: 00916749     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.jaci.2010.01.019     Document Type: Editorial

References (13)

1. Spitzer W.O., Suissa S., Ernst P., Horwitz R.I., Habbick B., Cockcroft D., et al. The use of b-agonists and the risk of death and near death from asthma. N Engl J Med 326 (1992) 501-506
2. Hargreave F.E., Dolovich J., and Newhouse M.T. The assessment and treatment of asthma: a conference report. J Allergy Clin Immunol 85 (1990) 1098-1111
3. Sheffer A.L., Bousquet J., Busse W.W., Clark T.J.H., Dahl R., Evans D., et al. International consensus report on diagnosis and management of asthma (1992), US Department of Health and Human Services, Bethesda Pub no. 92-3091
4. Suissa S., Ernst P., Benayoun S., Baltzan M., and Cai B. Low-dose inhaled corticosteroids and the prevention of death from asthma. N Engl J Med 343 (2000) 332-336
5. Bateman E.D., Reddel H.K., Eriksson G., Peterson S., Östlund O., and Sears M.R. Overall asthma control: The relationship between current control and future risk. J Allergy Clin Immunol 125 (2010) 600-608
6. Chapman K.R., Boulet L.P., Rea R.M., and Franssen E. Suboptimal asthma control: prevalence, detection and consequences in general practice. Eur Respir J 31 (2008) 320-325
7. Global Initiative. for Asthma (GINA). Global strategy for asthma management and prevention. 2007. Available at: www.ginasthma.com. Accessed February, 2009.
8. Rabe K.F., Atienza T., Magyar P., Larsson P., Jorup C., and Lalloo U.G. Effect of budesonide in combination with formoterol for reliever therapy in asthma exacerbations: a randomised controlled, double-blind study. Lancet 368 (2006) 744-753
9. Cates C.J., and Lasserson T.J. Combination formoterol and budesonide as maintenance and reliever therapy versus inhaled steroid maintenance for chronic asthma in adults and children. Cochrane Database Syst Rev 2 (2009) CD007313
10. O'Byrne P.M., Bisgaard H., Godard P.P., Pistolesi M., Palmqvist M., Zhu Y.J., et al. Budesonide/formoterol combination therapy as both maintenance and reliever medication in asthma. Am J Respir Crit Care Med 171 (2005) 129-136
11. Scicchitano R., Aalbers R., Ukena D., Manjra A., Fouquert L., Centanni S., et al. Efficacy and safety of budesonide/formoterol single inhaler therapy versus a higher dose of budesonide in moderate to severe asthma. Curr Med Res Opin 20 (2004) 1403-1418
12. Kuna P., Peters M.J., Manjra A.I., Jorup C., Naya I.P., Martinez-Jimenez N.E., et al. Effect of budesonide/formoterol maintenance and reliever therapy on asthma exacerbations. Int J Clin Pract 61 (2007) 725-736
13. Pavord I.D., Jeffery P.K., Qiu Y., Zhu J., Parker D., Carlsheimer A., et al. Airway inflammation in patients with asthma with high-fixed or low-fixed plus as-needed budesonide/formoterol. J Allergy Clin Immunol 123 (2009) 1083-1089